EBSCN(06178)

Search documents
诚达药业: 光大证券股份有限公司关于诚达药业股份有限公司2024年年度跟踪报告
Zheng Quan Zhi Xing· 2025-05-19 08:22
光大证券股份有限公司 关于诚达药业股份有限公司 保荐人名称:光大证券股份有限公司 被保荐公司简称:诚达药业 保荐代表人姓名:杨科 联系电话:021-22169999 保荐代表人姓名:范国祖 联系电话:021-22169999 一、保荐工作概述 项目 工作内容 (1)是否及时审阅公司信息披露文件 是 (2)未及时审阅公司信息披露文件的次数 0次 的情况 (1)是否督导公司建立健全规章制度(包 括但不限于防止关联方占用公司资源的制 是 度、募集资金管理制度、内控制度、内部 审计制度、关联交易制度) (2)公司是否有效执行相关规章制度 是 (1)查询公司募集资金专户次数 12 次 (2)公司募集资金项目进展是否与信息披 是 露文件一致 (1)列席公司股东会次数 0次 (2)列席公司董事会次数 0次 (1)现场检查次数 1次 (2)现场检查报告是否按照本所规定报送 是 (3)现场检查发现的主要问题及整改情况 无 (1)发表专项意见次数 6次 (2)发表非同意意见所涉问题及结论意见 无 (1)向本所报告的次数 0次 (2)报告事项的主要内容 不适用 (3)报告事项的进展或者整改情况 不适用 (1)是否存在需要关注的事项 ...
【固收】二级市场价格延续震荡上行,新增一只园区类REIT申报——REITs周度观察(20250512-20250516)(张旭)
光大证券研究· 2025-05-18 13:18
点击注册小程序 查看完整报告 特别申明: 本订阅号中所涉及的证券研究信息由光大证券研究所编写,仅面向光大证券专业投资者客 户,用作新媒体形势下研究信息和研究观点的沟通交流。非光大证券专业投资者客户,请勿 订阅、接收或使用本订阅号中的任何信息。本订阅号难以设置访问权限,若给您造成不便, 敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相关人员为光大 证券的客户。 报告摘要 1、 二级市场 2025年5月12日-2025年5月16日(以下简称"本周"),我国已上市公募REITs的二级市场价格整体呈现震荡 上行的趋势:加权REITs指数收于137.87,本周回报率为1.7%。与其他主流大类资产相比,回报率由高至 低排序分别为:美股>REITs>可转债>A股>纯债>原油>黄金。 从项目属性来看,本周产权类REITs和特许经营权类REITs均整体呈现震荡上行趋势,产权类REITs的涨幅 更大。 从底层资产类型来看,从底层资产类型来看,本周消费类REITs涨幅最大。本周回报率排名前三的底层资 产类型分别为消费类、园区类和保障房类。 从单只REIT层面来看,本周公募REITs涨跌互现,有52只REITs上 ...
【金工】市场小市值风格显著,大宗交易组合再创新高——量化组合跟踪周报20250517(祁嫣然/张威)
光大证券研究· 2025-05-18 09:44
查看完整报告 特别申明: 本订阅号中所涉及的证券研究信息由光大证券研究所编写,仅面向光大证券专业投资者客 户,用作新媒体形势下研究信息和研究观点的沟通交流。非光大证券专业投资者客户,请勿 订阅、接收或使用本订阅号中的任何信息。本订阅号难以设置访问权限,若给您造成不便, 敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相关人员为光大 证券的客户。 报告摘要 点击注册小程序 本周,基本面因子在多数行业表现较差,其中净利润增长率因子在煤炭行业正收益显著。估值类因子中, BP因子在综合行业正收益显著。流动性因子在交通运输、美容护理、化工、商业贸易和轻工制造行业正收 益显著。市值风格上,本周多数行业表现为小市值风格。 PB-ROE-50组合跟踪: 本周PB-ROE-50组合在中证500、中证800股票池中获取正超额收益。中证500股票池中获得超额收益 0.88%,中证800股票池中获得超额收益0.43%,全市场股票池中获得超额收益-0.02%。 量化市场跟踪 大类因子表现: 本周全市场股票池中,残差波动率因子和盈利因子分别获取正收益0.55%、0.26%;市值因子和非线性市值 因子分别获取负收益-0. ...
悦安新材: 光大证券股份有限公司关于江西悦安新材料股份有限公司2025年限制性股票激励计划首次授予相关事项之独立财务顾问报告
Zheng Quan Zhi Xing· 2025-05-16 14:02
Core Viewpoint - Jiangxi Yuenan New Materials Co., Ltd. has initiated a stock incentive plan for 2025, which includes the first grant of restricted stocks to selected employees and management, aimed at enhancing motivation and aligning interests with shareholders [1][6][15]. Summary by Sections Independent Financial Advisor Report - The independent financial advisor, Everbright Securities Co., Ltd., has confirmed that the stock incentive plan has undergone necessary approval procedures and complies with relevant regulations [6][15]. - The plan involves granting restricted stocks to 257 individuals, with a total of 1.8753 million shares allocated, adjusted from an initial 1.9173 million shares due to changes in eligible participants [8][15]. Approval Process - The approval process included discussions and resolutions at the board and supervisory committee meetings, ensuring that all necessary checks and balances were in place [6][7]. - The plan was publicly disclosed on the Shanghai Stock Exchange, ensuring transparency and compliance with regulatory requirements [8][15]. Grant Conditions - The grant of restricted stocks is contingent upon the fulfillment of specific conditions, including the absence of negative audit opinions and compliance with legal regulations [9][15]. - The vesting schedule for the restricted stocks is structured over a maximum of 60 months, with specific percentages vesting at designated intervals [11][12]. Impact on Financials - The implementation of the stock incentive plan is expected to have implications for the company's financial status and operational results, which will be assessed in accordance with accounting standards [16][17].
光大证券股份有限公司 关于山东省章丘鼓风机股份有限公司 向不特定对象发行可转换公司债券 持续督导保荐总结报告书
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-05-15 23:03
Core Viewpoint - The report summarizes the issuance of convertible bonds by Shandong Zhangqiu Blower Co., Ltd., detailing the amount raised, the use of funds, and the compliance with regulatory requirements [3][9][12]. Group 1: Issuer Basic Information - Shandong Zhangqiu Blower Co., Ltd. has registered capital as of the end of Q1 2025 [3]. - The company issued 2.43 million convertible bonds with a face value of RMB 100 each, raising a total of RMB 24.3 million [3]. Group 2: Fundraising Overview - The net amount raised after deducting issuance costs was RMB 238,629,781.92, with all funds received by October 23, 2023 [3]. - The issuance was approved by the China Securities Regulatory Commission (CSRC) [3]. Group 3: Due Diligence and Continuous Supervision - The sponsor conducted due diligence and complied with regulations during the issuance process, including responding to inquiries from the Shenzhen Stock Exchange [4]. - Continuous supervision included monitoring the company's governance structure and ensuring compliance with commitments and information disclosure [5][6]. Group 4: Fund Usage and Compliance - The company established a special account for the raised funds and has been managing them according to regulations, although there were instances of non-compliance in fund usage that were rectified [9][10]. - The company has been using idle funds for cash management, which is within the regulatory framework and does not affect the normal operation of fundraising projects [10][11]. Group 5: Conclusion on Fund Management - The sponsor concluded that the company's management of raised funds is compliant with relevant regulations, and there are no violations regarding the use of funds [12]. - As of December 31, 2024, some raised funds remain unutilized, and the sponsor will continue to oversee their usage [12].
对《持续稳定和活跃资本市场》的相关政策解读及券商板块展望
Xiangcai Securities· 2025-05-15 07:28
Investment Rating - The report maintains an "Overweight" rating for the securities industry [1] Core Insights - The report emphasizes the importance of a "sustained, stable, and active capital market" as a key driver for market sentiment and growth [6][7] - It highlights the significant growth in the securities industry, particularly in brokerage and proprietary trading, with a notable increase in revenue and net profit for listed brokers in Q1 2025 [36][37] Summary by Sections 1. Policy Interpretation on "Sustained, Stable, and Active Capital Market" - The report discusses recent policy measures aimed at stabilizing and invigorating the capital market, including support for long-term capital inflows and the promotion of new regulatory frameworks [8][7] - It outlines specific actions from the China Securities Regulatory Commission (CSRC) to enhance market liquidity and investor confidence [8] 2. Securities Industry Q1 2025 Performance Overview and Outlook - In Q1 2025, 42 listed brokers achieved revenues of CNY 125.93 billion, a year-on-year increase of 19%, and a net profit of CNY 52.18 billion, up 77.8% [37][38] - The fastest-growing segments were proprietary trading (up 45.5%) and brokerage services (up 43.2%), while investment banking and asset management saw slight declines [36][37] - The report notes that the average return on equity (ROE) for listed brokers improved to 8.05%, reflecting enhanced profitability across the sector [47][46] 3. Investment Recommendations - The report suggests that the ongoing reforms and market conditions present favorable investment opportunities within the securities sector, particularly in brokerage and proprietary trading [36][37] - It identifies potential benefits for underweighted sectors, indicating a shift in investment strategies towards areas with lower current allocations [15]
翔腾新材: 光大证券股份有限公司关于江苏翔腾新材料股份有限公司2024年度保荐工作报告
Zheng Quan Zhi Xing· 2025-05-14 09:25
务执行能力,完善投行三道防线内控体系建 设。 监会和深交所采取监管措施;翔腾新材不存 在被中国证监会和深交所采取监管措施的情 形。 | 光大证券股份有限公司关于江苏翔腾新材料股份有限公司2024年度 | | | --- | --- | | 保荐工作报告 | | | 保荐机构名称:光大证券股份有限公司 | 被保荐公司简称:翔腾新材 | | 保荐代表人姓名:黄腾飞 | 联系电话:021-22169999 | | 保荐代表人姓名:陈姝婷 | 联系电话:021-22169999 | | 一、保荐工作概述 | | | 项目 | 工作内容 | | (1)是否及时审阅公司信息披露文件 | 是 | | (2)未及时审阅公司信息披露文件的次数 | 0次 | | 情况 | | | (1)是否督导公司建立健全规章制度(包括 | | | 但不限于防止关联方占用公司资源的制度、 | | | 是 | | | 募集资金管理制度、内控制度、内部审计制 | | | 度、关联交易制度) | | | (2)公司是否有效执行相关规章制度 | 是 | | (1)查询公司募集资金专户次数 | 12 次 | | (2)公司募集资金项目进展是否与信息披露 ...
五洲医疗: 光大证券股份有限公司关于安徽宏宇五洲医疗器械股份有限公司2024年年度持续督导跟踪报告
Zheng Quan Zhi Xing· 2025-05-14 09:25
| 光大证券股份有限公司关于安徽宏宇五洲医疗器械股份有限公司 | | | | | | | --- | --- | --- | --- | --- | --- | | 保荐机构名称:光大证券股份有限公司 | | | 被保荐公司简称:五洲医疗 | | | | 保荐代表人姓名:黄腾飞 | | 联系电话:021-22169999 | | | | | 保荐代表人姓名:林剑云 | | 联系电话:021-22169999 | | | | | 一、保荐工作概述 | | | | | | | 项目 | 工作内容 | | | | | | (1)是否及时审阅公司信息披露文件 | 是 | | | | | | (2)未及时审阅公司信息披露文件的次数 | | 0次 | | | | | 情况 | | | | | | | (1)是否督导公司建立健全规章制度(包括 | | | | | | | 但不限于防止关联方占用公司资源的制度、 | | | | | | | 是 | | | | | | | 募集资金管理制度、内控制度、内部审计制 | | | | | | | 度、关联交易制度) | | | | | | | (2)公司是否有效执行相关规章制度 | ...
港股概念追踪|券商板块盈利能力与估值存在预期差 AH差价巨大存补涨空间(附概念股)
智通财经网· 2025-05-14 05:46
Core Insights - The leading Chinese securities firms are accelerating their strategic layout for Hong Kong IPOs, supported by coordinated domestic and foreign policies [1] - The performance of the brokerage industry is expected to significantly recover in 2024, driven by favorable policies, increasing proprietary income, and a low base effect from 2023 [1] - In 2025, continued market recovery is anticipated, with increases in stock trading volume, financing balance, and equity fund issuance, which will further boost wealth management income for brokerages [1] Industry Summary - Major brokerages are expected to see a substantial year-on-year increase in net profit in Q1 2025, with a 92% rise in net profit attributable to shareholders and a 51% increase in net profit excluding non-recurring items [1] - Three main trends are highlighted: 1. Continued expansion of total assets driven by financial investment scale, though there is a divergence in leverage ratios [1] 2. Growth in investment contributions, with major brokerages experiencing a general increase in investment-related income, indicating strong elasticity [1] 3. Recovery of light capital businesses, with a 71% year-on-year increase in average daily stock fund transaction volume and improvements in brokerage net income and investment banking net income [1] Future Outlook - The political bureau's meeting has set the tone for a stable and active capital market, with expectations for continued supportive policies for the capital market [1] - Attention is drawn to leading brokerages with strong balance sheet management and stable performance growth, as well as structural opportunities related to mergers and acquisitions [1] Related Companies - Companies with significant AH price differences include China International Capital Corporation (03908), CITIC Securities (06030), Everbright Securities (06178), CITIC Jiantou Securities (06066), Hongye Futures (03678), and GF Securities (01776) [2]
奥雅股份3年1期均亏损 上市即巅峰光大证券保荐
Zhong Guo Jing Ji Wang· 2025-05-13 07:15
中国经济网北京5月13日讯奥雅股份(300949)(300949.SZ)近日披露的2025年一季度报告显示,报告期 内,该公司实现营业收入8892.08万元,同比下降44.04%;实现归属于上市公司股东的净利润-932.57万 元,上年同期为-3859.06万元;实现归属于上市公司股东的扣除非经常性损益的净利润-1089.20万元, 较上年同期1160.96万元下降193.82%;经营活动产生的现金流量净额为3376.83万元,上年同期 为-2773.78万元。 2022年至2024年,奥雅股份实现营业收入分别为4.80亿元、4.79亿元和4.13亿元,实现归属于上市公司 股东的净利润分别为-5168.25万元、-1.77亿元和-2.82亿元,实现归属于上市公司股东的扣除非经常性损 益的净利润分别为-7626.32万元、-2.04亿元和-1.95亿元,经营活动产生的现金流量净额分别为-9080.02 万元、-1.17亿元和-2163.79万元。 上市首日,奥雅股份盘中最高价报143.00元,为该股上市以来最高价。该股目前处于破发状态。 奥雅股份首次公开发行股票募集资金总额为81,345.00万元,募集资金净额 ...